Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

Ixekizumab has known and some unexpected side effects.

Metformin can cause rare severe skin reactions.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

People with celiac disease have a higher risk of developing alopecia areata.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Gut bacteria differences could help diagnose and treat alopecia areata.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Modern lifestyles harm beneficial microbes, affecting health.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Skin reactions from cancer treatments might predict how well the treatments work.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Treg cells help repair and regenerate tissues by interacting with local cells.

Cannabinoids may help treat various skin conditions.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Enhancing glycolysis in mesenchymal stromal/stem cells boosts their immune functions and therapy potential.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Alopecia areata involves specific immune cells, offering potential treatment targets.

scINSIGHT accurately identifies cell clusters and gene patterns in complex data.

Microneedles can precisely deliver cancer treatments with fewer side effects.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Mouse models help understand alopecia areata and find treatments.

miR-200c-3p could help diagnose and treat alopecia areata.

The protein interleukin-1 alpha helps regenerate hair follicles and increase stem cell growth in mice.